Table 1.
Groups | Case | Age, years | Gender | Tissue locations | TNM staging |
---|---|---|---|---|---|
CSCC (n = 5) | Case 1 | 67 | Male | Cheek | pT2 pN1 Mx |
Case 2 | 71 | Male | Nose | pT2 pN1 M1 | |
Case 3 | 69 | Male | Nose | pT1 pNx M1 | |
Case 4 | 80 | Female | Cheek | pT3 pN1 M0 | |
Case 5 | 87 | Female | Nose | pT3 pN1 Mx | |
Bowen disease (n = 5) | Case 1 | 68 | Male | Cheek | Primary CSCC |
Case 2 | 73 | Male | Nose | Primary CSCC | |
Case 3 | 58 | Female | Nose | Primary CSCC | |
Case 4 | 75 | Female | Nose | Primary CSCC | |
Case 5 | 59 | Male | Cheek | Primary CSCC | |
Healthy controls (n = 5) | Case 1 | 81 | Female | Nose | — |
Case 2 | 64 | Male | Nose | — | |
Case 3 | 74 | Female | Cheek | — | |
Case 4 | 68 | Female | Nose | — | |
Case 5 | 65 | Male | Cheek | — | |
Statistics value | — | 1.382 | 0.536 | 0.000 | — |
P value | — | 0.288 | 0.765 | 1.000 | — |
The “—” indicated no significant differences